Integra LifeSciences Holdings Corporation - Common Stock (IART)
12.49
-0.79 (-5.95%)
NASDAQ · Last Trade: May 6th, 2:19 PM EDT
Detailed Quote
Previous Close | 13.28 |
---|---|
Open | 13.34 |
Bid | 12.47 |
Ask | 12.51 |
Day's Range | 12.40 - 13.80 |
52 Week Range | 11.60 - 32.66 |
Volume | 1,566,823 |
Market Cap | 1.06B |
PE Ratio (TTM) | -138.78 |
EPS (TTM) | -0.1 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 1,157,134 |
Chart
About Integra LifeSciences Holdings Corporation - Common Stock (IART)
Integra LifeSciences is a global medical technology company that specializes in regenerative therapies and neurosurgical products. The company focuses on developing innovative solutions for healthcare providers, particularly in the areas of wound healing, neurosurgery, and reconstructive surgery. Integra's product portfolio includes a range of advanced biomaterials, surgical instruments, and specialized medical devices designed to enhance patient outcomes and support surgical procedures. By leveraging cutting-edge technologies, the company aims to address complex medical challenges and improve the quality of life for patients worldwide. Read More
News & Press Releases
PHILADELPHIA, May 06, 2025 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · May 6, 2025
Shares of medical device company Integra LifeSciences (NASDAQ:IART)
fell 28.5% in the morning session after the company reported weak first-quarter 2025 results, which included a significant miss on full-year EPS guidance and the next quarter's revenue outlook.
Via StockStory · May 5, 2025
PHILADELPHIA, May 05, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (NASDAQ: AKRO):
By Grabar Law Office · Via GlobeNewswire · May 5, 2025
Medical device company Integra LifeSciences (NASDAQ:IART) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 3.7% year on year to $382.7 million. On the other hand, next quarter’s revenue guidance of $395 million was less impressive, coming in 5.3% below analysts’ estimates. Its non-GAAP profit of $0.41 per share was 4.9% below analysts’ consensus estimates.
Via StockStory · May 5, 2025
Medical device company Integra LifeSciences (NASDAQ:IART)
will be reporting results tomorrow before market open. Here’s what you need to know.
Via StockStory · May 4, 2025
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on.
But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
Via StockStory · April 29, 2025
PHILADELPHIA, April 28, 2025 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · April 28, 2025
The past year hasn't been kind to the stocks featured in this article.
Each has tumbled to their lowest points in 12 months, leaving investors to decide whether they're witnessing fire sales or falling knives.
Via StockStory · April 25, 2025
PHILADELPHIA, April 25, 2025 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · April 25, 2025
PHILADELPHIA, April 24, 2025 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · April 24, 2025
PHILADELPHIA, April 22, 2025 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · April 22, 2025
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at LeMaitre (NASDAQ:LMAT) and the best and worst performers in the surgical equipment & consumables - specialty industry.
Via StockStory · April 17, 2025
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - specialty stocks fared in Q4, starting with Teleflex (NYSE:TFX).
Via StockStory · April 15, 2025
PHILADELPHIA , April 11, 2025 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · April 11, 2025
PHILADELPHIA, April 07, 2025 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · April 7, 2025
PHILADELPHIA, April 04, 2025 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · April 4, 2025
PHILADELPHIA, March 31, 2025 (GLOBE NEWSWIRE) -- Holley Inc. (NYSE: HLLY) f/ka Empower Ltd. (NYSE: EMPW):
By Grabar Law Office · Via GlobeNewswire · March 31, 2025
PHILADELPHIA, March 27, 2025 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · March 27, 2025
Looking back on surgical equipment & consumables - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Integra LifeSciences (NASDAQ:IART) and its peers.
Via StockStory · March 27, 2025
PHILADELPHIA, March 25, 2025 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · March 25, 2025
PHILADELPHIA, March 24, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (NASDAQ: AKRO):
By Grabar Law Office · Via GlobeNewswire · March 24, 2025
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - specialty industry, including Intuitive Surgical (NASDAQ:ISRG) and its peers.
Via StockStory · March 24, 2025